{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:35:49Z","timestamp":1773858949387,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.mehy.2004.03.031","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T05:11:19Z","timestamp":1085807479000},"page":"834-837","source":"Crossref","is-referenced-by-count":13,"title":["S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia"],"prefix":"10.1016","volume":"63","author":[{"given":"Engin","family":"Altintas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Sezgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.03.031_BIB1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00001432-200112000-00015","article-title":"The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase","volume":"14","author":"Cameron","year":"2001","journal-title":"Curr. Opin. Infect. Dis"},{"key":"10.1016\/j.mehy.2004.03.031_BIB2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomized trial of interferon-a-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon-a-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.031_BIB3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon a-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"New Engl. J. Med"},{"issue":"4","key":"10.1016\/j.mehy.2004.03.031_BIB4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-199906000-00001","article-title":"Hemolytic anemia and the treatment of chronic hepatitis C","volume":"28","author":"Jaap","year":"1999","journal-title":"J. Clin. Gastroenterol"},{"issue":"6","key":"10.1016\/j.mehy.2004.03.031_BIB5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0168-8278(98)80138-4","article-title":"Severe anemia following combined alpha-interferon\/ribavirin therapy of chronic hepatitis C (letter)","volume":"29","author":"Tappero","year":"1998","journal-title":"J. Hepatol"},{"issue":"3","key":"10.1016\/j.mehy.2004.03.031_BIB6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.1840160307","article-title":"A pilot study of ribavirin therapy for chronic hepatitis C","volume":"16","author":"Di Bisceglie","year":"1992","journal-title":"Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.mehy.2004.03.031_BIB7","first-page":"32","article-title":"Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population","volume":"23","author":"Main","year":"1995","journal-title":"J. Hepatol"},{"issue":"3 Suppl 1","key":"10.1016\/j.mehy.2004.03.031_BIB8","doi-asserted-by":"crossref","first-page":"108S","DOI":"10.1002\/hep.510260719","article-title":"Therapy of hepatitis C: alpha interferon and ribavirin","volume":"26","author":"Reichard","year":"1997","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.mehy.2004.03.031_BIB9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.bmt.1700752","article-title":"Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections","volume":"19","author":"Sparrelid","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.mehy.2004.03.031_BIB10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.bjp.0701775","article-title":"Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters","volume":"123","author":"Jarvis","year":"1998","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.mehy.2004.03.031_BIB11","first-page":"17","article-title":"The clinical pharmacology of ribavirin","volume":"19","author":"Glue","year":"1999","journal-title":"Semin. Liver Dis"},{"key":"10.1016\/j.mehy.2004.03.031_BIB12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.510260236","article-title":"Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation","volume":"26","author":"Bizollon","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.mehy.2004.03.031_BIB13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/clpt.1987.70","article-title":"Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome","volume":"41","author":"Laskin","year":"1987","journal-title":"Clin. Pharmacol. Ther"},{"issue":"5","key":"10.1016\/j.mehy.2004.03.031_BIB14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0006-2952(94)90360-3","article-title":"Effects of novel anti-viral adenosine analogues on the activity of S-adenosylhomocysteine hydrolase from human liver","volume":"48","author":"Fabianowska-Majewska","year":"1994","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.mehy.2004.03.031_BIB15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","article-title":"S-adenosylmethionine and methylation","volume":"10","author":"Chiang","year":"1996","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.mehy.2004.03.031_BIB16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/BF01952867","article-title":"S-adenosyl-l-homocysteine: a non-cytotoxic hypomethylating agent","volume":"50","author":"De Cabo","year":"1994","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.mehy.2004.03.031_BIB17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ki.1995.31","article-title":"Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia","volume":"47","author":"Perna","year":"1995","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.mehy.2004.03.031_BIB18","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1016\/S0021-9258(18)42652-X","article-title":"Recognition of d-aspartyl residues in polypeptides by the erythrocyte l-isoaspartyl\/d-aspartyl protein methyltransferase. Implications for the repair hypothesis","volume":"267","author":"Lowenson","year":"1992","journal-title":"J. Biol. Chem"},{"issue":"2","key":"10.1016\/j.mehy.2004.03.031_BIB19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bj2100429","article-title":"Effect of analogues of 5\u2032-methylthioadenosine on cellular metabolism. Inactivation of S-adenosylhomocysteine hydrolase by 5\u2032-isobutylthioadenosine","volume":"210","author":"Della Ragione","year":"1983","journal-title":"Biochem J"},{"issue":"14","key":"10.1016\/j.mehy.2004.03.031_BIB20","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1046\/j.1432-1327.2000.01485.x","article-title":"Increased methyl esterification of altered aspartyl residues in erythrocyte membrane proteins in response to oxidative stress","volume":"267","author":"Ingrosso","year":"2000","journal-title":"Eur. J. Biochem"},{"issue":"1","key":"10.1016\/j.mehy.2004.03.031_BIB21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0009-8981(90)90237-M","article-title":"S-adenosylhomocysteine hydrolase and adenosine deaminase activities in human red cell ageing","volume":"189","author":"Bozzi","year":"1990","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.mehy.2004.03.031_BIB22","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1046\/j.1523-1755.2001.00747.x","article-title":"Plasma proteins containing damaged l-isoaspartyl residues are increased in uremia: implications for mechanism","volume":"59","author":"Perna","year":"2001","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.mehy.2004.03.031_BIB23","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1172\/JCI116485","article-title":"Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine","volume":"91","author":"Pema","year":"1993","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.mehy.2004.03.031_BIB24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jat.2550130307","article-title":"S-adenosyl-l-methionine prevents and reverses erythrocyte membrane alterations in cirrhosis","volume":"13","author":"Muriel","year":"1993","journal-title":"J. Appl. Toxicol"},{"issue":"3","key":"10.1016\/j.mehy.2004.03.031_BIB25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/cs0830353","article-title":"Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-l-methionine","volume":"83","author":"Rafique","year":"1992","journal-title":"Clin. Sci. (Lond)"},{"issue":"4","key":"10.1016\/j.mehy.2004.03.031_BIB26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF02777787","article-title":"Changes in lipid composition of erythrocyte membranes with administration of S-adenosyl-l-methionine in chronic liver disease","volume":"27","author":"Kakimoto","year":"1992","journal-title":"Gastroenterol. Jpn"},{"issue":"2","key":"10.1016\/j.mehy.2004.03.031_BIB27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1248\/cpb.39.468","article-title":"Interaction of pentoxifylline with human erythrocytes. III. Comparison of fluidity change of erythrocyte membrane caused by S-adenosyl-l-methionine with that by pentoxifylline","volume":"39","author":"Sato","year":"1991","journal-title":"Chem. Pharm. Bull. (Tokyo)"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704002567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704002567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T15:58:32Z","timestamp":1624377512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704002567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0306987704002567"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.03.031","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}